Abstract
In the GRADE approach, randomized trials start as high-quality evidence and observational studies as low-quality evidence, but both can be rated down if a body of evidence is associated with a high risk of publication bias. Even when individual studies included in best-evidence summaries have a low risk of bias, publication bias can result in substantial overestimates of effect. Authors should suspect publication bias when available evidence comes from a number of small studies, most of which have been commercially funded. A number of approaches based on examination of the pattern of data are available to help assess publication bias. The most popular of these is the funnel plot; all, however, have substantial limitations. Publication bias is likely frequent, and caution in the face of early results, particularly with small sample size and number of events, is warranted.
| Original language | English |
|---|---|
| Pages (from-to) | 1277-1282 |
| Number of pages | 6 |
| Journal | Journal of Clinical Epidemiology |
| Volume | 64 |
| Issue number | 12 |
| DOIs | |
| State | Published - Dec 2011 |
Keywords
- Conflict of interest
- Funnel plot
- GRADE
- Pharmaceutical industry
- Publication bias
- Quality of evidence
Fingerprint
Dive into the research topics of 'GRADE guidelines: 5. Rating the quality of evidence - Publication bias'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver